Status:
RECRUITING
Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs
Lead Sponsor:
International Agency for Research on Cancer
Collaborating Sponsors:
University of California, San Francisco
University of Zimbabwe
Conditions:
Cervical Cancer
Screening
Eligibility:
FEMALE
25-49 years
Phase:
NA
Brief Summary
Artificial intelligence (AI) is fast gaining reputation as a highly promising solution for cervical cancer screening. AI-based detection of cervical neoplasias is named automated visual exam (AVE) by ...
Detailed Description
Cervical cancer is a major public health challenge killing over 300,000 women annually at the most productive period of their lives and disproportionately affecting women in low- and middle-income cou...
Eligibility Criteria
Inclusion
- No cervical screening during the previous 3 years
- Between the ages of 25 and 49 years
- Understands and signs a written informed consent form
Exclusion
- Refusal to take part for any reason
- Actively menstruating or pregnant
- Treated earlier for cervical precancer or cancer
Key Trial Info
Start Date :
December 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
3200 Patients enrolled
Trial Details
Trial ID
NCT06042543
Start Date
December 9 2023
End Date
December 31 2027
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bothwell Guzha
Harare, Zimbabwe, 0002